The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with immunotherapy response for hepatocellular carcinoma.
 
Matthew Shing Hin Chung
No Relationships to Disclose
 
Rex Wan-Hin Hui
Travel, Accommodations, Expenses - Gilead Sciences
 
Lu Li
No Relationships to Disclose
 
Xianhua Mao
No Relationships to Disclose
 
Chi Leung Chiang
Honoraria - ASTRA ZENECA, TAIHO, ROCHE
Research Funding - ASTRA ZENECA, ROCHE, TAIHO
Travel, Accommodations, Expenses - Eisai
 
Carlos Wong
No Relationships to Disclose
 
Ian Chi Kei Wong
Leadership - Director of Jacobson Pharma (a generic company in HK)
Stock and Other Ownership Interests - UCL Spin-off company, Therakind, in the UK. HKU spin-off company, Advanced Data Analytics for Medical science in Hong Kong
Research Funding - Different Pharmaceutical Companies in big data analytics research (Inst)
 
Man Fung Yuen
Honoraria - Many companies with drugs for hepatitis B infection
Consulting or Advisory Role - Many companies with drugs for hepatitis B infection
Speakers' Bureau - Many companies with drugs for hepatitis B infection
Travel, Accommodations, Expenses - Many companies with drugs for hepatitis B infection
 
Wai-Kay Seto
Consulting or Advisory Role - Abbott; Gilead Sciences
Speakers' Bureau - Abbott; Echosens; Gilead Sciences
Research Funding - AstraZeneca, Alexion Pharmaceuticals, Boehringer Ingelheim, Pfizer and Ribo Life Science; Gilead Sciences
 
Lung-Yi Mak
Travel, Accommodations, Expenses - ChongLap; Gilead Sciences; Otsuka